Constantly seek and gather knowledge
The Scientific Committee will assist the company in evaluating its product development and make recommendations, give professional assessment/recommendations/decisions on the company'sdevelopment strategy/pipeline deployment/production process and give professional assessment/recommendation/decision making.
Joined Fojann Biopharmaceuticals limited in February 2025.
Holds a Master's in Hospital Administration and a Ph.D. in Public Health from the University of Alabama at Birmingham, USA. Is a licensed physician in the United States and board-certified in Clinical Pathology in the USA. Formerly served as a Senior Medical Reviewer at the U.S. FDA, being the first Chinese national studying abroad to enter the FDA's clinical review process as a physician. Dr. Li Changqing possesses extensive global clinical trial experience across Phases I-IV in areas such as oncology, immunotherapy, anti-inflammatory, gastrointestinal diseases, and gynecological diseases. He has led hundreds of clinical trials
Shanghai Public Network Anbei 31011502402974